Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling (WP3612)

Homo sapiens

Open in new tab Open in NDEx
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads
Photodynamic therapy may induce an antioxidant response mediated by NFE2L2. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3612 CPTAC Assay Portal]

Authors

Ruud Weijer , Kristina Hanspers , Friederike Ehrhart , and Alex Pico

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Disease Ontology

cancer

Pathway Ontology

altered regulatory pathway

Participants
Query Drugst.One

Label Type Compact URI Comment
GCLM GeneProduct ncbigene:2730
GCLC GeneProduct ncbigene:2729
GSTP1 GeneProduct ncbigene:2950
JUN GeneProduct ncbigene:3725
ABCG2 GeneProduct ncbigene:9429
FOS GeneProduct ncbigene:2353
ABCC3 GeneProduct ncbigene:8714
ABCC2 GeneProduct ncbigene:1244
KEAP1 GeneProduct ncbigene:9817
ABCC4 GeneProduct ncbigene:10257
ABCC6 GeneProduct ncbigene:368
HMOX1 GeneProduct ncbigene:3162
MAPK12 GeneProduct ncbigene:6300
MAPK13 GeneProduct ncbigene:5603
MAPK11 GeneProduct ncbigene:5600
NFE2L2 GeneProduct ncbigene:4780
MAPK14 GeneProduct ncbigene:1432
MAPK8 GeneProduct ncbigene:5599
KEAP1 GeneProduct ncbigene:9817
NFE2L2 GeneProduct ncbigene:4780
NFE2L2 GeneProduct ncbigene:4780
EPHX1 GeneProduct ncbigene:2052
CES1 GeneProduct ncbigene:1066
NQO2 GeneProduct ncbigene:4835
SRXN1 GeneProduct ncbigene:140809
NQO1 GeneProduct ncbigene:1728

References

  1. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Broekgaarden M, Weijer R, van Gulik TM, Hamblin MR, Heger M. Cancer Metastasis Rev. 2015 Dec;34(4):643–90. PubMed Europe PMC Scholia
  2. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells. Weijer R, Broekgaarden M, van Golen RF, Bulle E, Nieuwenhuis E, Jongejan A, et al. BMC Cancer. 2015 Dec 26;15:1014. PubMed Europe PMC Scholia